Nanobiotechnology Department, Faculty of Innovative Science and Technology, Razi University, Kermanshah, Iran.
Family and Community Medicine Department, College of Medicine, University of Duhok, Duhok, Iraq.
Cell Mol Biol (Noisy-le-grand). 2022 Feb 4;67(5):151-156. doi: 10.14715/cmb/2021.67.5.21.
Antibiotic resistance in pathogenic bacteria to various types of antibiotics has resulted in the necessity of new effective strategies to get around this problem. In recent investigations, metal or metal oxide nanoparticles specifically silver nanoparticles (AgNPs) have been employed successfully to hinder antibiotic-resistant Gram-negative and Gram-positive bacteria. However, AgNPs at high concentrations have cytotoxicity for eukaryotic cells which, application of other biocompatible materials particularly plant secondary metabolites of curcumin and quercetin to reduce cytotoxicity is a critical affair. These compounds may be used directly or indirectly to produce AgNPs. In this regard, modified NPs by curcumin and quercetin have shown an increased therapeutic effect and biocompatibility and biodegredibility properties. Therefore, here, recent advances and challenges about antibacterial and biocompatibility properties of nanoformulation of AgNPs with curcumin and quercetin are presented.
抗生素耐药性在各种类型的抗生素中的致病性细菌已经导致新的有效策略来解决这个问题的必要性。在最近的调查中,金属或金属氧化物纳米粒子,特别是银纳米粒子(AgNPs)已经成功地被用来阻止抗生素耐药的革兰氏阴性和革兰氏阳性细菌。然而,高浓度的 AgNPs 对真核细胞具有细胞毒性,应用其他生物相容性材料,特别是姜黄素和槲皮素的植物次生代谢产物来降低细胞毒性是一个关键的问题。这些化合物可以直接或间接地用来生产 AgNPs。在这方面,用姜黄素和槲皮素修饰的 NPs 显示出增加的治疗效果和生物相容性和生物降解性。因此,在这里,提出了关于用姜黄素和槲皮素制备的 AgNPs 的纳米制剂的抗菌和生物相容性的最新进展和挑战。